THE CHEMISTRY, PHARMACOKINETICS AND TISSUE DISTRIBUTION OF PIPERACILLIN TAZOBACTAM

被引：148

作者：

SORGEL, F

KINZIG, M

机构：

[1] Institute for Biomedical and Pharmaceutical Research, Nornberg-Heroldsberg, W-8501

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1993年 / 31卷

关键词：

D O I：

10.1093/jac/31.suppl_A.39

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The pharmacokinetic properties of piperacillin/tazobactam are summarized. The data on piperacillin show that the behaviour of this well established agent is the same when given in combination with tazobactam as when given alone. Tazobactam shows pharmacokinetic characteristics typical of a β-lactam compound. It distributes mainly into the extracellular space and shows typical tissue penetration behaviour. The tissue concentrations of piperacillin and tazobactam and their pharmacokinetic profiles in plasma and tissues encourage the view that the synergy observed in vitro will be reflected in clinical use. © 1993 The British Society for Antimicrobial Chemotherapy.

引用

页码：39 / 60

页数：22

共 35 条

[11]

Johnson J.R., 1949, CHEM PENICILLIN, P440

[12]

JUNG D, 1984, CLIN CHEM, V30, P122

[13] EVALUATION OF PIPERACILLIN-TAZOBACTAM IN EXPERIMENTAL MENINGITIS CAUSED BY A BETA-LACTAMASE-PRODUCING STRAIN OF K1-POSITIVE ESCHERICHIA-COLI [J].

KERN, W ;

KENNEDY, SL ;

SACHDEVA, M ;

SANDE, ER ;

GUNDERSON, D ;

TAUBER, MG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :697-701

[14] PHARMACOKINETICS AND TISSUE PENETRATION OF TAZOBACTAM AND PIPERACILLIN IN PATIENTS UNDERGOING COLORECTAL SURGERY [J].

KINZIG, M ;

SORGEL, F ;

BRISMAR, B ;

NORD, CE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1997-2004

[15]

KINZIG M, 1991, 31ST P INT C ANT AG

[16]

KINZIG M, 1991, 17TH P INT C CHEM BE

[17]

LATHIA C, 1991, Pharmaceutical Research (New York), V8, pS303

[18]

MINAMI Y, 1991, 31ST P INT C ANT AG

[19]

MUTH P, 1991, J CHEMOTHERAPY S4, V4, P227

[20]

NABER KG, 1991, 17TH P INT C CHEM BE

← 1 2 3 4 →